Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Characterization of BCR-ABL Specific CD4+ T Cells and Their Role in Controlling Ph+ Acute Lymphoblastic Leukemia

Sean I. Tracy, MD PhD, Can Hekim, MSc,PhD, Michael Farrar, PhD

Blood (2019) 134 (Supplement_1): 1345.

https://doi.org/10.1182/blood-2019-124205

Published: 2019

Journal Articles

Role of IGF2BP1 and Target Genes in ETV6-RUNX1 Positive B-Acute Lymphoblastic Leukemia

Jayanth Kumar Palanichamy, MD, Gunjan Sharma, MSc, Thakur Nidhi, MBBS, Anita Chopra, MD DM, Sameer Bakhshi, MD

Blood (2019) 134 (Supplement_1): 3818.

https://doi.org/10.1182/blood-2019-128019

Published: 2019

Journal Articles

A Case of CCDC6-RET Fusion Mutation in Adult Acute Lymphoblastic Leukemia (ALL), a Known Activating Mutation Unreported in ALL

Mateo Mejia Saldarriaga, MD, Amir Steinberg, MD, Adam F. Binder, MD

Blood (2018) 132 (Supplement 1): 5136.

https://doi.org/10.1182/blood-2018-99-112652

Published: 2018

Journal Articles

Successful Salvage with Inotuzumab Ozogamicin in Relapsed/Refractory Lymphoid Blast Crisis of Chronic Myeloid Leukemia after Failure of Multiple Lines of Therapy Including Blinatumomab

Alay Mansurov, MD, Michael Byrne, MD, Koyamangalath Krishnan, MD

Blood (2018) 132 (Supplement 1): 5452.

https://doi.org/10.1182/blood-2018-99-114170

Published: 2018

Journal Articles

Heterogeneous BCR-ABL Signal Patterns Identified By Fluorescence in Situ Hybridization Can Predict Leukemic Clonal Evolution and Poor Prognosis in BCR-ABL-Positive Leukemia

Zhang Zhanglin, Wan Lagen, Jiang Mei, Liu Shuyuan, Guo Yang, Li Fei, PhD MD

Blood (2017) 130 (Supplement 1): 1441.

https://doi.org/10.1182/blood.V130.Suppl_1.1441.1441

Published: 2017

Journal Articles

Evaluation of Genetic Mutations in Plasma Exosomes As a Biomarker Tool for Detecting the Clonal Evolution of Leukemic Cells in Pediatric AML

Fabienne Kunz, Katarina Reinhardt, PhD, Nils Von Neuhoff, PhD, Karl Welte, MD, Dirk Reinhardt, MD PhD, Basant Kumar Thakur, PhD

Blood (2016) 128 (22): 1711.

https://doi.org/10.1182/blood.V128.22.1711.1711

Published: 2016

Journal Articles

Epidemiology Data of Patients with Chronic Myeloid Leukemia in West Central Mexico

Virginia Campos-Cabrera, QFB EBC, Jose-Luis Campos-Villagomez, MD, Salvador Campos-Cabrera, MD, Gregorio Campos-Cabrera, MD

Blood (2016) 128 (22): 5462.

https://doi.org/10.1182/blood.V128.22.5462.5462

Published: 2016

Journal Articles

Telomere Length Shortening in the CML Leukemic Stem Cell Compartment Correlates with the Respective Clone Size: Evidence for Early Vs. Late Chronic Phase

Anne-Sophie Bouillon, Monica S. Ferreira, PhD, Shady Adnan Awad, Johan Richter, MD, Henrik Hjorth-Hansen, MD PhD, Thoas Fioretos, Sebastian Hummel, Mirle Schemionek, PhD, Satu Mustjoki, MD PhD, Fabian Beier, MD, Tim H. Brümmendorf, MD

Blood (2016) 128 (22): 4243.

https://doi.org/10.1182/blood.V128.22.4243.4243

Published: 2016

Journal Articles

Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL), Tawam Experience

Arif Alam, MBBS, Khaled al Qawasmeh, Jihad Kanbar, Masood H Syed, MBBS, Amar Lal, MD, Sabir Hussain, MD, Hani Y Osman, Jorgen Kristensen, MD PhD

Blood (2015) 126 (23): 4867.

https://doi.org/10.1182/blood.V126.23.4867.4867

Published: 2015

Journal Articles

Combination of Anti-CD123 and Anti-CD19 Chimeric Antigen Receptor T Cells for the Treatment and Prevention of Antigen-Loss Relapses Occurring after CD19-Targeted Immunotherapies

Marco Ruella, MD, David M. Barrett, MD PhD, Saad S Kenderian, MD, Olga Shestova, PhD, Ted J. Hofmann, PhD, John Scholler, Simon F. Lacey, PhD BSc, J. Joseph Melenhorst, PhD, Farzana Nazimuddin, Jessica Perazzelli, PhD, David A Christian, PhD, Christopher A Hunter, PhD, David L Porter, MD, Carl H. June, MD, Stephan A. Grupp, MD PhD, Saar I Gill, MBBS, PhD

Blood (2015) 126 (23): 2523.

https://doi.org/10.1182/blood.V126.23.2523.2523

Published: 2015

Journal Articles

Concurrent or Sequential BCR-ABL Translocation and Calr gene or JAK2 V617F Mutation

Maria Pagoni, Maria Garofalaki, Irene Tziotziou, Evaggelia Nikolou, Stamatis Karakatsanis, Ioannis Tsonis, Katerina Zoi, Ioannis Baltathakis, Dimitrios Karakasis, Nikolaos Harhalakis

Blood (2014) 124 (21): 1844.

https://doi.org/10.1182/blood.V124.21.1844.1844

Published: 2014

Journal Articles

Extramedullary Hematopoiesis and Splenic Vein Thrombosis, a Unique Presentation Of Pre-Clinical Essential Thrombocythemia

Abdulraheem Yacoub, MD, MB, BS, Abigail Brockman, RN, BSN

Blood (2013) 122 (21): 5257.

https://doi.org/10.1182/blood.V122.21.5257.5257

Published: 2013

Journal Articles

Development and Validation Of Highly Sensitive Mrdx BCR-ABL Test For Monitoring Deep Molecular Response In Patients With Chronic Myeloid Leukemia

Julie Toplin, Kristy Drafahl, Jonathan Eibl, Clark Fjeld, Thomas Yager, Staci McAdams, Kevin Hawkins, Chad Galderisi

Blood (2013) 122 (21): 2617.

https://doi.org/10.1182/blood.V122.21.2617.2617

Published: 2013

Journal Articles

Telomere Shortening At Diagnosis Of Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Is Significantly More Pronounced In Patients With Less-Than-Optimal Versus Optimal Molecular Response (ELN criteria) After 12 Months Of Treatment With Nilotinib

Katrin Wenn, Lena Tomala, Fabian Beier, MD, Stefan Wilop, MD, Lucia Vankann, Christian Hasenbank, Oliver Frank, Claudia Walasek, Andreas Hochhaus, MD, Frank Giles, MD MB, Steffen Koschmieder, Patrick Ziegler, PhD, Tim H. Brümmendorf, MD

Blood (2013) 122 (21): 1471.

https://doi.org/10.1182/blood.V122.21.1471.1471

Published: 2013

Journal Articles

Chronic Myeloid Leukemia (CML) Patients With Atypical e1a2 P190 BCR-ABL Translocation Show a Poor Response To Therapy With Tyrosine Kinase Inhibitors (TKI)

Carme Montoriol-Sabaté, Carolina Martínez-Laperche, PhD, P Jiménez-Gámiz, Rosa Collado, PhD, Alfredo Minguela-Puras, M.A. Piñán-Francés, B. Bellosillo, Joaquín Martínez-López, MD, PhD, Marcos González, MD, María José Larrayoz, PhD, MªJose Calasanz, PhD, Maria Teresa Gomez-Casares, MD, G. González-Brito, Gloria Soler, Jose Román, A. Jimenez-Velasco, Ismael Buno, PhD

Blood (2013) 122 (21): 5193.

https://doi.org/10.1182/blood.V122.21.5193.5193

Published: 2013

Journal Articles

Donor Cell Derived Leukemia: Description Of 38 Cases and a Case Control Study

Nicole Engel, MD, Rafael F. Duarte, MD, PhD, Myriam Labopin, MD, Thomas Schroeder, MD, Johanna Tischer, MD, Per T. Ljungman, MD, PhD, Nicolaas PM Schaap, MD, PhD, Denis Guyotat, MD, Yves Beguin, MD, PhD, Arnon Nagler, MD, MSc, Wilfried A. Schroyens, MD, PhD, Grzegorz Wladyslaw Basak, M.D., Ph.D., Hans Jochem Kolb, MD, Manuela Badoglio, Andre Tichelli, MD, Alicia Rovo, MD

Blood (2013) 122 (21): 914.

https://doi.org/10.1182/blood.V122.21.914.914

Published: 2013

Journal Articles

Loss of the Y Chromosome Predicts Lower Complete Cytogenetic Remission Rate in Patients (pts) with Chronic Myeloid Leukemia (CML)

Mohamed Abdelfatah, Adel Al-Alwan, Zeyad Kanaan, Mark R Litzow, MD, Alexandra Wolanskyj, Kebede Begna, William Hogan, MD, Daniel L. Van Dyke, Ph.D., Aref Al-Kali, MD

Blood (2012) 120 (21): 4804.

https://doi.org/10.1182/blood.V120.21.4804.4804

Published: 2012

Journal Articles

Expanding Spectrum of Malignancies in ALPS: A Cancer Predisposing Syndrome?.

Katie Perkins, NP, Joie Davis, NP, Susan Price, RN, Julie Niemela, PhD, Andreas R. Huber, MD, Donna A. Wall, MD, Stefania Pittaluga, MD, PhD, Thomas A. Fleisher, MD, V. Koneti Rao, MD

Blood (2012) 120 (21): 2149.

https://doi.org/10.1182/blood.V120.21.2149.2149

Published: 2012

Journal Articles

Quantitative modeling of chronic myeloid leukemia: insights from radiobiology

Tomas Radivoyevitch, Lynn Hlatky, Julian Landaw, Rainer K. Sachs

Blood (2012) 119 (19): 4363–4371.

https://doi.org/10.1182/blood-2011-09-381855

Published: 2012

Includes: Supplemental data

Journal Articles

High Incidence of Primary Resistance to Imatinib in the Group of Ph-Negative BCR-ABL- positive CML Patients,

Grigory Tsaur, Olga Plekhanova, Alexander Popov, Tatyana Riger, Anna Ivanova, Yulia Gryaznova, Ekaterina Nokhrina, Bulat Bakirov, Irina Krylova, Sergey Meresiy, Marina Shumkova, Egor Shorikov, Leonid Saveliev, Larisa Fechina

Blood (2011) 118 (21): 3772.

https://doi.org/10.1182/blood.V118.21.3772.3772

Published: 2011

NARROW

Characterization of BCR-ABL Specific CD4+ T Cells and Their Role in Controlling Ph+ Acute Lymphoblastic Leukemia

Role of IGF2BP1 and Target Genes in ETV6-RUNX1 Positive B-Acute Lymphoblastic Leukemia

A Case of CCDC6-RET Fusion Mutation in Adult Acute Lymphoblastic Leukemia (ALL), a Known Activating Mutation Unreported in ALL

Successful Salvage with Inotuzumab Ozogamicin in Relapsed/Refractory Lymphoid Blast Crisis of Chronic Myeloid Leukemia after Failure of Multiple Lines of Therapy Including Blinatumomab

Heterogeneous BCR-ABL Signal Patterns Identified By Fluorescence in Situ Hybridization Can Predict Leukemic Clonal Evolution and Poor Prognosis in BCR-ABL-Positive Leukemia

Evaluation of Genetic Mutations in Plasma Exosomes As a Biomarker Tool for Detecting the Clonal Evolution of Leukemic Cells in Pediatric AML

Epidemiology Data of Patients with Chronic Myeloid Leukemia in West Central Mexico

Telomere Length Shortening in the CML Leukemic Stem Cell Compartment Correlates with the Respective Clone Size: Evidence for Early Vs. Late Chronic Phase

Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL), Tawam Experience

Combination of Anti-CD123 and Anti-CD19 Chimeric Antigen Receptor T Cells for the Treatment and Prevention of Antigen-Loss Relapses Occurring after CD19-Targeted Immunotherapies

Concurrent or Sequential BCR-ABL Translocation and Calr gene or JAK2 V617F Mutation

Extramedullary Hematopoiesis and Splenic Vein Thrombosis, a Unique Presentation Of Pre-Clinical Essential Thrombocythemia

Development and Validation Of Highly Sensitive Mrdx BCR-ABL Test For Monitoring Deep Molecular Response In Patients With Chronic Myeloid Leukemia

Telomere Shortening At Diagnosis Of Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Is Significantly More Pronounced In Patients With Less-Than-Optimal Versus Optimal Molecular Response (ELN criteria) After 12 Months Of Treatment With Nilotinib

Chronic Myeloid Leukemia (CML) Patients With Atypical e1a2 P190 BCR-ABL Translocation Show a Poor Response To Therapy With Tyrosine Kinase Inhibitors (TKI)

Donor Cell Derived Leukemia: Description Of 38 Cases and a Case Control Study

Loss of the Y Chromosome Predicts Lower Complete Cytogenetic Remission Rate in Patients (pts) with Chronic Myeloid Leukemia (CML)

Expanding Spectrum of Malignancies in ALPS: A Cancer Predisposing Syndrome?.

Quantitative modeling of chronic myeloid leukemia: insights from radiobiology

High Incidence of Primary Resistance to Imatinib in the Group of Ph-Negative BCR-ABL- positive CML Patients,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only